Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of Moderate-to-Severe Atopic Dermatitis in Children?
Presented by the Atopic Dermatitis & Psoriasis Focused Study Group, and moderated by Dr. Minnelly Luu, Drs. Amy Paller, Elaine Siegfried, Jeff Yu, and A. Yasmine Kirkorian have a spirited discussion about the safety of JAK inhibitors in children, what interventions to try first, and the research that is still needed. Listen to learn more.
Minnelly Luu, MD
Associate Professor of Clinical Dermatology, Keck School of Medicine of USC
Amy Paller, MD
Chair of the Department of Dermatology, Walter J. Hamlin Professor of Dermatology and Professor of Pediatrics at Northwestern Fienberg School of Medicine
Elaine Siegfried, MD
Professor of Pediatrics and Dermatology, St. Louis University School of Medicine
A. Yasmine Kirkorian
Chief of Dermatology, Children’s National Hospital
JiaDe (Jeff) Yu, MD
Assistant Professor of Adult and Pediatric Dermatology, Massachusetts General Hospital